 Vigabatrin rational treatment chronic epilepsy Vigabatrin selective irreversible suicide inhibitor GABA transaminase increases brain CSF GABA adult patients long refractory epilepsy treatment standard anti-convulsant drugs addition vigabatrin weeks reduction seizure frequency patients reduction frequency seizure types week double-blind placebo phase Patients vigabatrin reduction seizure frequency placebo increase seizure frequency significant difference groups open phase patients due unacceptable reversible adverse events commonest side effects drowsiness depression mood instability headaches Vigabatrin valuable new treatment chronic epilepsy partial seizures secondary generalisation